LIFE - CIK 0001339970
The table below shows aTYR PHARMA INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $10.01M | $6.15M | $17.22M | $10.36M | $11.46M | $6.80M |
| Short-term investments | - | $79.00M | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $67.58M |
| $93.01M |
| $87.49M |
| $83.27M |
| $76.32M |
| $90.30M |
| Property, plant & equipment | $4.24M | $4.43M | $4.53M | $4.68M | $5.02M | $5.18M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $79.65M | $106.65M | $101.53M | $97.25M | $91.62M | $105.94M |
| Accounts payable | $2.75M | $4.06M | $3.88M | $1.53M | $3.95M | $1.25M |
| Total current liabilities | $11.70M | $15.68M | $15.53M | $10.68M | $14.12M | $11.84M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | -$616.96M | -$592.20M | -$566.46M | -$546.93M | -$517.08M | -$499.82M |
| Total equity | $57.93M | $80.23M | $74.84M | $75.05M | $65.33M | $81.61M |